March 11, 2020 / 1:06 PM / a month ago

BRIEF-Acasti Pharma Accelerates Plans To Submit FDA Meeting Request By March End

March 11 (Reuters) - Acasti Pharma Inc:

* ACASTI PHARMA AWARDED NOTICE OF ALLOWANCE FOR ADDITIONAL COMPOSITION OF MATTER AND METHOD OF USE PATENTS IN THE UNITED STATES AND MEXICO

* ACASTI PHARMA INC - COMPLETES TRILOGY 1 AUDITS AND ACCELERATES PLANS TO SUBMIT FDA MEETING REQUEST BY END OF MARCH

* ACASTI PHARMA INC - PATENT UPHELD IN JAPAN FOLLOWING OPPOSITION FILINGS AND SUBSEQUENTLY ALLOWED Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below